Rumors are swirling about potential Actos Bladder Cancer settlements. According to Bloomberg News, Takeda Pharmaceutical Co. has indicated that it will pay more than $2.2 billion to settle Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker tentatively agrees to settle more than 8,000 Actos bladder cancer lawsuits in federal…
Zofran, is an anti-nausea medication that is commonly prescribed for post surgical, chemotherapy and morning sickness patients over the past 20 years. According to experts, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children. GlaxoSmithKline Allegations Patients have…
As a Dallas Xarelto Bleeding Death attorney and Texas medical doctor, I would like to update my readers about the ongoing status of the Xarelto litigation. Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen. Danny Julien recently…
Cook Medical is exposed to a personal injury and product liability claim by a Michigan man, who blames the Celect Inferior Vena Cava filter for causing severe injury when it broke apart and punctured his heart. Larry and Brenda Johnson recently filed a lawsuit in the U.S. District Court for…
After 4 years of intense Actos litigation, surrounding the link between the use of Actos and the development of bladder cancer, Takeda Pharmaceuticals is signaling the raising of the white flag, by entering into a series of settlement discussions. Serious effort are underway to try and resolve all of the…
Johnson and Johnson (J&J) the world’s largest pharmaceutical and medical device maker is hammered in another loss in the on going transvaginal mesh wars. In the latest of a series of trials held in state and federal court, the jury has awarded $5.7 million verdict against J&J and its Ethicon…
According to a FDA press release this week, testosterone drug makers must change the products’ labels to warn they are approved for only certain disorders, not to help men treat aging symptoms. Popular blockbuster drugs, like AbbVie Inc.’s AndroGel and Eli Lilly & Co.’s Axiron, are being restricted and warnings…
Johnson & Johnson, (J&J) the world’s largest pharmaceutical and medical device maker recently received a one, two punch over its antipsychotic blockbuster drug, Risperdal. The drug manufacturer lost the first trial in state court in Philadelphia over allegations that Risperdal causes gynecomastia or abnormal breast growth in boys and young…
According to court documents and a review of the inventory of filed lawsuits against the makers of Xarelto, the litigation appears to be gathering steam and increasing in breadth and depth. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted consolidated pretrial proceedings for all federal Xarelto…
DePuy ASR metal on metal hip replacements continue to fail prematurely and require painful and risky revision surgery. Johnson and Johnson, the world’s largest pharmaceutical and medical device maker and its subsidiary DePuy, recently agreed to extend the settlement of its notorious line of failed metal on metal hips, to…